NDAORALSUSPENSION
Approved
Sep 2018
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
15
Mechanism of Action
Pharmacologic Class:
Benzothiazole
Clinical Trials (5)
A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
Started Feb 2025
Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets
Started Jun 2021
Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
Started Mar 2021
Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder
Started Dec 2020
Real-World Data Study of Troriluzole-Treated Patients With Spinocerebellar Ataxia (SCA) Compared to a Matched Natural History Control
Started Mar 2019
Loss of Exclusivity
LOE Date
Mar 12, 2029
36 months away
Patent Expiry
Mar 12, 2029
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 8765150 | Mar 12, 2029 | Product | U-2401 |